LexaGene Intends to Pursue Full Panel Pathogen Testing through the FDA

NEXT STORY
Valeo Pharma Announces Upsize of Previously Announced Bought Deal Private Placement of Convertible Debentures to $15 Million With Concurrent $10 Million Private Placement From Investissement Quebec
PREV STORY
Global Materiovigilance Market to Surpass US$ 113.5 Billion by 2028, Says Coherent Market Insights (CMI)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Elucida Oncology Appoints Dr. Eliel Bayever as Chief Medical Officer

author_avatar
NASDAQ Market News

Generex Announces Acquisition of Additional 38% of Subsidiary Olaregen Therapeutix in an Up-Market Transaction with a Share Exchange of GNBT Stock at $2.50

author_avatar
NASDAQ Market News

Medivir proceeds with a separation of the company’s operations

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Board of ...

author_avatar
NASDAQ Market News